Phase II

Here is a list of phase II trials that the Medelis team has completed.

Study Indication Sites Patients Services* Countries
Phase II Metastatic liver cancer – image guided surgery system

3

75

Full service United States
Phase II Metastatic liver cancer – image guided surgery system

2

60

Full service United States
Phase II Metastatic liver cancer – image guided surgery system

2

32

Medical Monitoring/DSMB United States
Phase II Recurrent epithelia ovarian cancer

5

40

Full service Unites States
Phase II Advanced sarcoma

4

36

PM/CM United States
Phase II Advanced multiple myeloma

7

60

PM/CM United States
Phase II Malignant ascites in ovarian cancer patients

13

39

Full service United States
Phase II Advanced ovarian cancer

12

47

Full service United States
Phase II Non-small cell lung cancer

8

210

Full service United States
Phase II Locally advanced pancreatic cancer

10

40

Start-up/CM/PM Canada, United States
Phase II Breast cancer with progression of previously irradiated brain metastases

8

31

Start-up/patient recruitment United States
Phase II Metastatic colorectal

4

33

PM/CM United States
Phase II Idiopathic thrombocytopenic purpura (ITP)

40

80

Feasibility assessment/start-up United States
Phase II Chronic lymphocytic leukemia

1

20

Full service UK
Phase II Chronic lymphocytic leukemia

20

60

Feasibility assessment UK, France, Denmark, Sweden, Poland
Phase II Non-small cell lung cancer

4

13

Full service UK
Phase II Pediatric ALL

25

100

Feasibility assessment France, UK, Netherlands, Belgium

If you’d to talk to us about our experience or your study, contact us.